Scout | Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk

This opportunity is no longer accepting applications.

grant

Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk

This grant opportunity is seeking innovative research projects that explore the effects of long-term use of incretin mimetics on cancer risk and outcomes. Researchers should focus on how these drugs impact individuals, considering different time frames due to the varying latency of cancer development after exposure. A minimum of one year of incretin mimetic use is expected to be analyzed. Appl…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Dates

Opportunity Released: March 7, 2024

Keywords

Incretin Mimetics

Epidemiologic Studies

Cancer Risk

Recurrent Cancer

Long-term Exposure

Comorbid Conditions

Clinical Data Sets

Latency Period

Exogenous Exposure

Cancer Outcomes

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers